Soda et al. discovered the fusion of the anaplastic lymphoma kinase (ALK) gene with echinoderm microtubule–associated protein like 4 (EML4) in NSCLC as a novel molecular target for cancer therapy [3]. This evidence concerns the gene ALK and non-small cell lung carcinoma.